万维提示：
1、投稿方式：在线投稿。
2、期刊网址：https://www.geriatriconcology.net/
https://www.journals.elsevier.com/journal-of-geriatric-oncology
3、投稿网址：
https://www.editorialmanager.com/JGERIONC
4、期刊刊期：一年出版8期。
2021年8月26日星期四
投稿须知【官网信息】
Guide for Authors
The Journal of Geriatric Oncology is an international, multidisciplinary journal focused on advancing research in the pathogenesis, biology, treatment, and survivorship issues of older adults with cancer. The journal covers all aspects of geriatric oncology, from basic scientific research through to clinical research, as well as research that is relevant to education and policy development.
This journal operates a single blind review process. All contributions will be initially assessed by the editors for suitability for the journal. The Editor-in-Chief or Deputy Editor is responsible for the final decision regarding acceptance or rejection of articles. The Editor's decision is final. More information on types of peer review.
The Journal of Geriatric Oncology publishes original research articles, review articles (including systematic reviews), clinical trials and clinical trial protocols, treatment guidelines, research letters, and letters to the editor which comment on previously published work. Publication types such as Editorials, "Geriatrics for the Oncologist", perspectives, and "How I treat" are generally solicited by or require approval from the Editor-in-Chief. Papers deemed suitable by the Editors are generally sent to a minimum of two independent expert reviewers to assess the scientific quality of the paper. Research letters, letters to the editor, and perspectives may only require one review or review by an Editor.
The Journal of Geriatric Oncology is the official journal of the International Society of Geriatric Oncology (SIOG).
Manuscript categories and guidelines
The Journal of Geriatric Oncology publishes articles in the following categories:
Editorials: Editorials are invited by the Editor-in-Chief. Editorials do not have an abstract or keywords and should be limited to 1,500 words in length. References should be limited to 15 or less. Editorials generally do not include Figures or Tables, but may include one if needed.
Original Research Articles: Original, full-length research papers which have not been published previously may be submitted. Original research papers should include a structured abstract (350 words) and should be divided into sections (Introduction, Materials and Methods, Results and Discussion). They should not exceed 3,500 words in length. All original research must include a statement assuring review by an institutional review or ethical board. Original Research Articles can include up to 7 Tables and/or Figures. While there is no limit to references, references should be as contemporary as possible and only essential references should be included.
Papers reporting the results of clinical trials may be submitted and should follow the format of original research articles.
Review Articles: Review articles which are topical and which are a critical assessment of any aspect of geriatric oncology may be submitted. Review articles should include an unstructured abstract [350 words]. They should not exceed 5,000 words in length.Review articles can include up to 7 Tables and/or Figures. While there is no limit to references, references should be as contemporary as possible and only essential references should be included.
Systematic reviews: Systematic Reviews with or without a meta-analyses are preferred over narrative reviews. These should include a structured abstract (350 words). They should not exceed 5,000 words in length. Systematic review articles can include up to 7 Tables and/or Figures. While there is no limit to references, references should be as contemporary as possible and only essential references should be included.
Systematic reviews, with or without a meta-analysis, MUST attach the completed checklist. Systematic reviews and meta-analyses that determine diagnostic accuracy should be reported according to QUADAS (Quality Assessment of Studies of Diagnostic Accuracy included in Systematic Reviews). It is recommended that all systematic reviews be registered a priori with PROSPERO.
……
更多详情：
https://www.elsevier.com/journals/journal-of-geriatric-oncology/1879-4068/guide-for-authors
